A systematic review of the evidence for long term outcomes of tapering opioid doses in patients on long term opioid therapy for chronic pain from the Veterans Affairs Evidence Synthesis Program (ESP). The report analyzes published studies to determine the benefits and harms for patients when tapering their opioid medications to lower doses or discontinuation and reviews whether benefits and harms vary by
This 2019 systematic review assesses the evidence for the effectiveness of behavioral health interventions as part of a medication-assisted treatment (MAT) regimen for opioid use disorder (OUD). The report also evaluates clinical practice guideline recommendations for behavioral health treatments as a part of MAT and describes 3 service delivery models that implement low-threshold MAT programs in Missouri, Virginia and in the Veterans Health Administration.
The Yale School of Medicine’s website contains comprehensive resources for providers interested in setting up a program to initiate buprenorphine treatment for individuals with opioid use disorder (OUD) seen in the emergency department (ED).
This 20 minute Real Talk podcast features one physician’s personal experience of having a family member addicted to opioids.
In the 1990s, the Substance Abuse and Mental Health Services Administration provided grants to create family-centered, residential substance use disorder treatment programs that allowed children to reside with their parents. This 2004 case study looks at the Families in Transitions program
This research study summary looks at Project Nurture, an integrated prenatal and postpartum care program for pregnant mothers with substance use disorder and their infants.
The Bexar County, Texas Neonatal Abstinence Syndrome (NAS) collaborative works to improve outcomes for mothers and infants affected by substance use disorder.
This 2019 report from the American Academy of Pediatrics provides recommendations to the Indian Health Service on appropriate assessment and treatment of neonatal opioid withdrawal syndrome (NOWS) in American Indian and Alaskan Native (AI/AN) populations.
This document provides a template for an EPIC electronic health record note for documenting that the service was provided via telemedicine due to the COVID-19 pandemic.
This 4-page guide from the Providers Clinical Support System is designed to provide information for clinicians on using telemedicine to treat opioid use disorder (OUD) during the COVID-19 pandemic. This guide includes frequently asked questions about prescribing medications for OUD during this time,